Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 90.1% in April

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 768,300 shares, a growth of 90.1% from the March 31st total of 404,200 shares. Based on an average trading volume of 1,575,100 shares, the short-interest ratio is presently 0.5 days. Approximately 0.0% of the shares of the company are short sold.

Bayer Aktiengesellschaft Trading Up 0.5 %

Bayer Aktiengesellschaft stock opened at $6.60 on Wednesday. Bayer Aktiengesellschaft has a 52 week low of $4.79 and a 52 week high of $8.58. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.81 and a current ratio of 1.32. The firm has a market capitalization of $25.94 billion, a PE ratio of -25.38 and a beta of 0.93. The business’s 50-day simple moving average is $6.12 and its 200-day simple moving average is $5.80.

Bayer Aktiengesellschaft Increases Dividend

The firm also recently declared a dividend, which will be paid on Monday, May 12th. Stockholders of record on Wednesday, April 30th will be issued a dividend of $0.0224 per share. The ex-dividend date of this dividend is Tuesday, April 29th. This is a positive change from Bayer Aktiengesellschaft’s previous dividend of $0.02. This represents a dividend yield of 0.38%. Bayer Aktiengesellschaft’s payout ratio is -2.78%.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.